ReviewPlants (Basel, Switzerland)2025
Cannabidiol's Antioxidant Properties in Skin Care Products and Legislative Regulations.
Review in Plants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Skin on Drugs: Psychotropic Compounds in Cutaneous Biology.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cannabidiol (CBD) has garnered interest in its potential antioxidant properties in skin care. This review synthesizes the current literature exploring CBD's role as an antioxidant and anti-inflammatory cosmetic ingredient and its impact on skin health. CBD exhibits antioxidant effects by scavenging free radicals, reducing oxidative stress, and mitigating inflammation, all of which contribute to aging and skin conditions like acne and dermatitis. CBD interacts with the endocannabinoid system and other cellular pathways to bolster antioxidant defenses in skin cells. The search engines were Google Scholar, Scopus, and PubMed. The search was performed using the main keywords "liposomal CBD and keratinocytes", "antioxidant properties of CBD and keratinocytes", "anti-inflammatory activity of CBD and keratinocytes", "CBD and cosmetics", "CBD and skin care products", and "CBD and cosmetic products regulation" for the period 2018-2025. The period for the search of the literature was chosen based on the legalization of medical cannabis. Its non-psychoactive nature and favorable safety profile make CBD a compelling candidate for inclusion in skin care formulations seeking natural and effective antioxidant solutions. As consumer demand for botanical-based skin care rises, CBD stands out for its promising therapeutic benefits and potential applications in anti-aging and dermatological treatments. Despite its benefits, using CBD in cosmetics is not without its challenges. The varying legal status of CBD in various jurisdictions is confusing to both the cosmetic industry and consumers. Some jurisdictions allow CBD to be derived from hemp, while others may prohibit its use. The legal and regulatory status of CBD is a constantly changing matter. The purpose of the article is to review the liposomal forms of encapsulated CBD to increase its percutaneous absorption and therefore its antioxidant, anti-inflammatory effect on keratinocytes. Liposomal CBD firstly bypasses the problems of insolubility of free radicals and secondly protects it from various exogenous oxidizing agents, while maintaining its activity. CBD is a valuable antioxidant agent in skin care science, suggesting avenues for further research and product development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.